|
|
Evidence supports 1) strategies to minimize the risk of acquiring infectious disease that may trigger exacerbations of MS; and 2) the safety of using influenza, hepatitis B, varicella, tetanus, and Bacille Calmette-Guerin (BCG) vaccines in p atients with MS. |
|